Sun Pharma local and regional leadership team toasts to the future of CARMELIN for the Filipino patient
Sun Pharmaceutical Industries, the world’s fourth-largest specialty generic pharmaceutical company, officially launched its Primary Care Division in the Philippines with the unveiling of the CaRMeLin Portfolio — a comprehensive therapeutic line dedicated to Cardiometabolic, Renal, Liver, and Alimentary care.
The scientific launch event gathered many of the country’s top Key Opinion Leaders in internal medicine, cardiology, endocrinology, nephrology, and primary care, making it one of the most distinguished medical assemblies of the year. This milestone marks Sun Pharma’s formal and strategic entry into the largest therapeutic segment in Philippine healthcare.
